Spinoff to tap RNA's promise
Scripps Florida has launched a new spinoff company, its second.
Claes Wahlestedt, director of Central Nervous System drug discovery at Scripps Florida, has teamed up with Delray Beach angel investor Joe Collard to launch cuRNA, a firm that will try to develop therapeutic drugs based on RNA, the lesser-known sibling to DNA.
Pharmaceutical companies and biotech investors have been drawn to RNA in recent years for its unique role in regulating and suppressing the expression of genes in the body. So far, just one RNA-based drug exists. Many others are in clinical trials.
|
